CHICAGO (Reuters) - Two studies in monkeys published on Wednesday offer some of the first scientific evidence that surviving COVID-19 may result in immunity from reinfection, a positive sign that vaccines under development may succeed, U.S. researchers said on Wednesday.
Although scientists have assumed that antibodies produced in response to the new coronavirus virus are protective, there has been scant scientifically rigorous evidence to back that up.
In one of the new studies, researchers infected nine monkeys with COVID-19, the illness caused by the novel coronavirus. After they recovered, the team exposed them to the virus again and the animals did not get sick.
The findings suggest that they “do develop natural immunity that protects against re-exposure,” said Dr. Dan Barouch, a researcher at the Center for Virology and Vaccine Research at Harvard’s Beth Israel Deaconness Medical Center in Boston, whose studies were published in the journal Science.
“It’s very good news,” Barouch said.
Several research teams have released papers - many of them not reviewed by other scientists - suggesting that a vaccine against the virus would be effective in animals.
In the second study, Barouch and colleagues tested 25 monkeys with six prototype vaccines to see if antibodies produced in response were protective.
They then exposed these monkeys and 10 control animals to SARS-CoV-2, the official name of the novel coronavirus.
All of the control animals showed high degrees of virus in their noses and lungs, but in the vaccinated animals, “we saw a substantial degree of protection,” Barouch said. Eight of the vaccinated animals were completely protected.
These studies, which have been peer reviewed, do not prove that humans develop immunity or how long it might last, but they are reassuring.
“These data will be seen as a welcome scientific advance,” Barouch said.
Reporting by Julie Steenhuysen; Editing by Bill Berkrot
GLOBAL GATHERING RECOMMENDS
WASHINGTON (AP) — Former President Barack Obama on Saturday criticized U.S. leaders overseeing the nation’s response to the coronavirus, telling college graduates in an online commencement address that the pandemic shows many officials “aren’t even pretending to be in charge.” Obama spoke on “...
WASHINGTON — An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday. Study volunteers given either a low or medium dose of the vaccine by Cambr...
NEW YORK (AP) — New York City’s death toll from the coronavirus may be thousands of fatalities worse than the tally kept by the city and state, according to an analysis released Monday by the U.S. Centers for Disease Control and Prevention. Between March 11 and May 2, about 24,000 more people ...
The coronavirus pandemic is straining social safety nets across the globe — and underlining sharp differences in approach between wealthy societies such as the United States and Europe. In Europe, the collapse in business activity is triggering wage support programs that are keeping millions ...
WASHINGTON (AP) — The U.S. unemployment rate rocketed to 14.7% in April, a level last seen during the Great Depression, as 20.5 million jobs vanished in the worst monthly loss on record — stark evidence of how the coronavirus has brought the economy to its knees.
WASHINGTON (AP) — Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated. About 100 research groups are...
LONDON (Reuters) - Britain will trial a new coronavirus tracing programme next week on the Isle of Wight, just off the south coast of England, cabinet minister Michael Gove said on Sunday as the government looks at how to minimise the risk of a second wave of infection. Suffering one of the w...
WASHINGTON (AP) — U.S. regulators on Friday allowed emergency use of an experimental drug that appears to help some coronavirus patients recover faster. It is the first drug shown to help fight COVID-19, which has killed more than 230,000 people worldwide. President Donald Trump announced...